Emcure Pharma partnered with Roche for distribution of key nephrology and transplant medicines (CellCept, Mircera, Neorecormon) in India. This strategic move expands Emcure's portfolio and reach, strengthening its position in renal care and anemia management, aiming to improve patient access to critical therapies.